ClinicalTrials.gg
RecruitingNCT07941908SCS-BCI RehabUpdated Nov 17, 2026

Spinal Cord Stimulation Combined With Brain-Computer Interface Rehabilitation to Improve Motor Function After Stroke

An observational study in Poststroke Hemiplegia, sponsored by Qingdao Central Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Qingdao Central Hospital · Observational

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 613 studies in Stroke with a site in China — 242 open to participants now, 263 under way, 21 of them phase 3. Stroke · China.

Planned enrollment
171st of 180
40 · median 611
Started
2026
with 65 others
Observational
181 of 613
78 open now
Primary completion
2027-09
later than 177 of 262 live
Registered
609th of 613
by date

Among the 613 studies in Stroke with a site in China, this one is the 171st largest by planned enrollment of the 180 observational ones that give a count, is one of 66 that started in 2026, is one of 181 observational ones, reaches primary completion later than 177 of the 262 other live ones, and was the 609th registered.

Stroke

8,279 studies on the registry are indexed under Stroke; 2,066 are open to participants now.

Browse Stroke studies →

Open to participants now

242 of the 613 studies in Stroke with a site in China are open now. Recruiting first, the newest first:

236 more — sign in →

All 242 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 1,421 Stroke studies recruiting now, 698 (49%) set no upper age limit and 282 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 613 studies in Stroke with a site in China, or all of them as a file.
02

Study summary

This study evaluates the effects of spinal cord stimulation (SCS) combined with brain-computer interface (BCI)-assisted rehabilitation on motor function in patients with post-stroke hemiplegia using multisource neurophysiological data. In this single-group study with repeated measurements, participants undergo four weeks of SCS combined with BCI-driven upper- and lower-limb rehabilitation. Immediate motor performance is compared between SCS ON and OFF conditions under standardized tasks. Changes in motor function and multisource neurophysiological and kinematic measures are also assessed before and after rehabilitation to characterize treatment responses and explore their relationships with clinical motor improvement.

Read the detailed description

This is a single-group study using a within-participant pre-post design with repeated measurements. The study enrolls patients with post-stroke hemiplegia who meet the clinical indications for spinal cord stimulation (SCS) surgery and require SCS treatment. Following preoperative baseline assessment, participants undergo SCS implantation based on clinical indications, followed by stimulation parameter adjustment, individualized brain-computer interface (BCI) model calibration, and rehabilitation device setup.

The study includes four weeks of SCS combined with BCI-assisted synchronized upper- and lower-limb active rehabilitation. The first week includes postoperative recovery, stimulation parameter adjustment, and early closed-loop training. During rehabilitation, the BCI system identifies motor intentions from electroencephalography (EEG) signals in real time and drives upper- and lower-limb rehabilitation robots to provide corresponding assisted movements, establishing a closed-loop process integrating motor intention, robotic assistance, and sensorimotor feedback. Training is planned for three to five sessions per week, with 45-60 minutes of effective training per session.

Repeated measurements under SCS ON and OFF conditions are performed to evaluate the immediate effects of stimulation. With BCI closed-loop tasks, robotic assistance settings, and movement requirements held constant, motor performance during affected upper-limb, lower-limb, and synchronized upper- and lower-limb tasks is compared between SCS OFF and ON conditions. At least one standardized ON/OFF comparison is conducted each week during the intervention period.

Assessments are conducted at the preoperative baseline (T0), postoperative immediate-effect assessment (T1), week-2 mid-intervention assessment (T2), week-4 endpoint assessment (T3), and follow-up (T4). Clinical motor function assessments and multisource data, including EEG, functional near-infrared spectroscopy, electromyography, electrodermal activity, upper- and lower-limb kinematics, and BCI control logs, are used to evaluate changes in motor function, cortical activity, muscle activation patterns, interlimb coordination, and BCI closed-loop performance. Relationships between objective measures and improvements in clinical motor function are also examined.

03

Conditions studied

  • Poststroke Hemiplegia

Keywords

  • Spinal Cord Stimulation
  • Stroke
  • Hemiplegia
  • Motor Function
  • Post-Stroke
  • Brain-Computer Interface
  • Electroencephalography
  • Functional Near-Infrared Spectroscopy
  • Electromyography
  • Synchronized Active Robotic Rehabilitation
  • Multisource Neurophysiological Data
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of adults aged 18 to 75 years with imaging-confirmed ischemic or hemorrhagic stroke and unilateral hemiplegia. Participants must meet the clinical indications for spinal cord stimulation (SCS) implantation and be scheduled to undergo SCS surgery for clinical reasons. They must be clinically stable and able to complete brain-computer interface (BCI) calibration, synchronized upper- and lower-limb rehabilitation assessments, and multisource physiological data collection

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18-75 years.
  2. Patients who meet the clinical indications for SCS surgery, require SCS to improve their condition, and plan to undergo the procedure at the study center.
  3. Ischemic or hemorrhagic stroke confirmed by CT or MRI.
  4. Unilateral hemiplegia with assessable motor dysfunction in both the affected upper and lower limbs.
  5. Stable clinical condition and ability to cooperate with SCS implantation surgery, BCI calibration, synchronized upper- and lower-limb robotic rehabilitation, and collection of all multisource physiological data.
  6. Adequate cognitive and comprehension abilities to complete motor imagery or motor-attempt tasks and meet the requirements for BCI modeling and closed-loop control.
  7. Meets the clinical indications for epidural SCS implantation based on neurosurgical evaluation.
  8. Body size, joint range of motion, and tolerance of sitting or standing are compatible with the safe use of upper- and lower-limb rehabilitation robots.
  9. Written signed by the patient or their legally authorized representative.

Exclusion criteria

Exclusion Criteria

  1. Severe cognitive impairment, complete aphasia, or severe unilateral spatial neglect that prevents completion of all study tasks.
  2. Uncontrolled epilepsy or frequent seizures during the previous three months.
  3. to surgery or anesthesia, including severe cardiopulmonary disease, coagulation disorders, or active systemic infection.
  4. Implanted electronic medical devices with electromagnetic compatibility conflicts involving the SCS system, EEG/fNIRS brain recording devices, or rehabilitation robots.
  5. Severe limb contracture, persistent severe pain, structural joint injury, or positional intolerance that prevents standardized synchronized rehabilitation training.
  6. Skin lesions or skin disorders on the head or limbs that prevent the use of EEG, fNIRS, EMG, or electrodermal sensors.
  7. Any other condition judged by the investigator to make participation in the study inappropriate.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • SCS Combined With BCI-Assisted Synchronized Upper- and Lower-Limb Active Rehabilitation

    All participants receive SCS combined with EEG-driven BCI-assisted synchronized upper- and lower-limb active rehabilitation. After baseline assessment, SCS implantation, and parameter adjustment, participants complete four weeks of training and weekly SCS ON/OFF comparisons under consistent BCI tasks and robotic assistance settings. Clinical motor outcomes, multisource neurophysiological signals, kinematics, and BCI control logs are collected

    Device: Spinal Cord Stimulation (SCS) · Device: Brain-Computer Interface Active Rehabilitation System

Interventions

  • DeviceSpinal Cord Stimulation (SCS)

    An epidural SCS system is used, comprising stimulation electrodes, a pulse generator or external stimulator, a programming system, and an event recording system. The clinical team determines the stimulation target according to motor impairments, surgical safety, and the established treatment plan. Standardized SCS OFF and ON comparisons are performed under consistent BCI tasks and robotic assistance settings, with stimulation parameters, motor performance, and related physiological data recorded

  • DeviceBrain-Computer Interface Active Rehabilitation System

    The BCI active rehabilitation system identifies motor intention during imagery or attempted movement from real-time EEG signals and triggers corresponding assisted movements using upper- and lower-limb rehabilitation robots, forming a closed loop between motor intention, sensory feedback, and limb movement. Rehabilitation continues for four weeks, three to five times per week (preferably five), with 45-60 minutes of effective training per session. At least one standardized SCS ON/OFF comparison is performed weekly

    Also known as: EEG-Driven BCI-Assisted Synchronized Upper- and Lower-Limb Active Rehabilitation

06

What researchers measure

Primary outcomes

  1. Difference in Immediate Motor Task Performance Between SCS ON and OFF Conditions

    Motor performance during affected upper-limb, lower-limb, and synchronized upper- and lower-limb tasks is compared between SCS ON and OFF conditions, with BCI closed-loop mode and robotic assistance parameters kept consistent, to evaluate the immediate effects of SCS

    Time frame: Intervention weeks 1-4 (T1-T3)

  2. Change in Upper- and Lower-Extremity Fugl-Meyer Assessment Scores

    The Fugl-Meyer Assessment (FMA) is used to evaluate changes in upper- and lower-extremity motor function separately before and after four weeks of combined rehabilitation

    Time frame: Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)

  3. Pearson/Spearman Correlation Between Multisource Objective Measures and Clinical Motor Improvement

    Pearson or Spearman correlation analysis will be performed to examine the correlation between multisource neurophysiological measures (EEG, fNIRS, EMG, electrodermal), kinematic parameters, and BCI closed-loop performance metrics, and the change in Fugl-Meyer Assessment (FMA) score, to identify objective features linked to the effects of combined rehabilitation.

    Time frame: Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)

Secondary outcomes

  1. Change in 10-Meter Walk Test Speed

    Walking ability is assessed using the 10-Meter Walk Test.

    Time frame: T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

  2. Change in Modified Ashworth Scale Scores

    Changes in spasticity of the affected upper and lower limbs are assessed using the Modified Ashworth Scale

    Time frame: T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

  3. Changes in Motor-Related EEG Features

    Changes in movement-related EEG rhythms, movement-related cortical potentials, and motor intention decoding features are assessed

    Time frame: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

  4. Changes in Motor-Area fNIRS Hemodynamic Responses

    Changes in motor-area hemodynamic responses during motor tasks are assessed using functional near-infrared spectroscopy (fNIRS)

    Time frame: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

  5. Changes in Upper- and Lower-Limb EMG Activity and Muscle Synergies

    Changes in target-muscle activation, active contribution, abnormal muscle synergies, co-contraction, and interlimb temporal coupling are assessed using upper- and lower-limb electromyography (EMG)

    Time frame: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

  6. Changes in Electrodermal Responses and Stimulation Tolerability

    Electrodermal responses and stimulation tolerability are evaluated using electrodermal signals and records of stimulation-related discomfort

    Time frame: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), including assessments during the 4-week intervention period

  7. Changes in Upper- and Lower-Limb Kinematics and Coordination

    Changes in movement speed, smoothness, trajectory deviation, joint range of motion, gait or pedaling symmetry, and interlimb coordination are assessed

    Time frame: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

  8. BCI Decoding and Closed-Loop Control Performance

    BCI performance is evaluated using decoding accuracy, valid trigger rate, false trigger rate, control latency, robotic task completion rate, assistance level, and online model stability

    Time frame: From initial BCI calibration (T0, 1-2 weeks before surgery) to end of intervention week 4 (T3), with follow-up assessment at T4 (4 weeks after SCS electrode removal)

  9. Safety, Training Completion, and Data Acquisition Quality

    SCS-, BCI-, and robotic device-related adverse events, training completion, device tolerability, and the completeness and quality of synchronized upper- and lower-limb data acquisition are recorded

    Time frame: During the 4-week intervention after SCS implantation, with final assessment at T4 (4 weeks after SCS electrode removal)

  10. Change in Berg Balance Scale Score

    Balance function is assessed using the Berg Balance Scale.

    Time frame: T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Liu H, Yang L, Wang H, et al. Spinal Cord Stimulation for Poststroke Hemiparesis: A Scoping Review of Upper and Lower Limb Efficacy. Arch Phys Med Rehabil. 2024;105(8):1521-1532
  • Chen D, Shi J, Tao B, Zhao X, Zhao Z, Li S, Xu Y, Ding T, Zhang P, Ye Q, Chen K, Wu Z, Tang Y, Jiang W, Shu K, Huang L, You Z, Zhang P, Tang Z. A Novel Transfer Learning-Based Hybrid EEG-fNIRS Brain-Computer Interface for Intracerebral Hemorrhage Rehabilitation. Adv Sci (Weinh). 2025 Nov;12(43):e05426. doi: 10.1002/advs.202505426. Epub 2025 Aug 19. PubMed 40831229 ↗
  • Kathe C, Skinnider MA, Hutson TH, Regazzi N, Gautier M, Demesmaeker R, Komi S, Ceto S, James ND, Cho N, Baud L, Galan K, Matson KJE, Rowald A, Kim K, Wang R, Minassian K, Prior JO, Asboth L, Barraud Q, Lacour SP, Levine AJ, Wagner F, Bloch J, Squair JW, Courtine G. The neurons that restore walking after paralysis. Nature. 2022 Nov;611(7936):540-547. doi: 10.1038/s41586-022-05385-7. Epub 2022 Nov 9. PubMed 36352232 ↗
  • Liang J, Song Y, Belkacem AN, Li F, Liu S, Chen X, Wang X, Wang Y, Wan C. Prediction of balance function for stroke based on EEG and fNIRS features during ankle dorsiflexion. Front Neurosci. 2022 Aug 18;16:968928. doi: 10.3389/fnins.2022.968928. eCollection 2022. PubMed 36061607 ↗
  • Bastos T, Villa-Parra AC, Guerrero-Méndez CD, et al. Towards Upper- and Lower-Limb Rehabilitation of Post-Stroke Patients through Brain-Computer Interface, Cerebrospinal Stimulation and Robotic Devices. In: Biosystems and Biorobotics. Springer; 2024:689-692
  • Alawieh H, Liu D, Madera J, Kumar S, Racz FS, Fey AM, Del R Millan J. Electrical spinal cord stimulation promotes focal sensorimotor activation that accelerates brain-computer interface skill learning. Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2418920122. doi: 10.1073/pnas.2418920122. Epub 2025 Jun 10. PubMed 40493186 ↗
  • Li R, Li S, Roh J, Wang C, Zhang Y. Multimodal Neuroimaging Using Concurrent EEG/fNIRS for Poststroke Recovery Assessment: An Exploratory Study. Neurorehabil Neural Repair. 2020 Dec;34(12):1099-1110. doi: 10.1177/1545968320969937. Epub 2020 Nov 16. PubMed 33190571 ↗
  • Privitera L, Lassi M, Dalise S, Azzollini V, Maggiani L, Guggisberg A, Mazzoni A, Chisari C, Micera S, Bandini A. A multimodal machine learning approach to forecast upper limb motor recovery after stroke using kinematic and electromyographic data - A pilot-study. J Neuroeng Rehabil. 2026 Jan 5;23(1):31. doi: 10.1186/s12984-025-01796-5. PubMed 41486155 ↗
  • Ali U, Khan JA, Ahsan MT, Altaf B, Azreen S, Alamu OS, Rana MS. Brain-Computer Interfaces in the Rehabilitation of Stroke and Spinal Cord Injury: A Systematic Review and Meta-Analysis of Clinical Efficacy. Cureus. 2025 Oct 17;17(10):e94833. doi: 10.7759/cureus.94833. eCollection 2025 Oct. PubMed 41257158 ↗
  • Powell MP, Verma N, Sorensen E, Carranza E, Boos A, Fields DP, Roy S, Ensel S, Barra B, Balzer J, Goldsmith J, Friedlander RM, Wittenberg GF, Fisher LE, Krakauer JW, Gerszten PC, Pirondini E, Weber DJ, Capogrosso M. Epidural stimulation of the cervical spinal cord for post-stroke upper-limb paresis. Nat Med. 2023 Mar;29(3):689-699. doi: 10.1038/s41591-022-02202-6. Epub 2023 Feb 20. PubMed 36807682 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared with external researchers. Study data will be used for analyses within this research project. Study findings will be reported in aggregate form while protecting participant privacy

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Sep 2027, 11 months later.

Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 11 months is below that.

Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 22, 2026
First posted
Nov 17, 2026
StartEst.
Oct 21, 2026
Primary completionEst.
Sep 30, 2027
CompletionEst.
Mar 31, 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07941908
Lead sponsor
Qingdao Central Hospital
Collaborators
Shandong University
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Oct 21, 2026 (estimated)
Primary completion
Sep 30, 2027 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Nov 17, 2026

Study contacts

Feng Jin, MD
Contact
jinfengsdjn@163.com
+8617685739716
Feng Jin, MD
Contact
jinfengsdjn@163.com
+86 17685739716
Feng Jin, MD
principal investigator · Qingdao Central Hospital, University of Health and Rehabilitation Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion